Cellogen Therapeutics announced that it has received around $2 million in a round of funding on January 17, 2024. The transaction included participation from new investor, NATCO Pharma Limited.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,041 INR | +0.87% | +4.21% | +28.34% |
May. 28 | INDIA STOCKS-Metal, pharma stocks drive Indian benchmarks higher | RE |
May. 28 | Transcript : NATCO Pharma Limited, Q4 2024 Earnings Call, May 28, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.34% | 2.22B | |
+39.22% | 727B | |
+30.57% | 592B | |
-7.85% | 347B | |
+15.48% | 319B | |
-0.12% | 274B | |
+12.55% | 238B | |
+6.65% | 204B | |
-6.09% | 203B | |
-3.37% | 160B |
- Stock Market
- Equities
- NATCOPHARM Stock
- News NATCO Pharma Limited
- Cellogen Therapeutics announced that it has received $2 million in funding from NATCO Pharma Limited